Modifies provisions relating to gender transition procedures
Summary
HB 1016 repeals and replaces Missouri’s existing section 191.1720 with a new law titled the “Missouri Save Adolescents from Experimentation (SAFE) Act.” The bill prohibits healthcare providers from performing gender transition surgery on anyone under 18 and from prescribing or administering cross-sex hormones or puberty-blocking drugs to minors for the purpose of gender transition. It also defines key terms such as biological sex, gender transition, gender-transition surgery, cross-sex hormones, and puberty-blocking drugs.
The bill creates a limited grandfather clause for minors who were already receiving cross-sex hormones or puberty-blocking drugs before August 28, 2023, allowing that treatment to continue only until March 1, 2026. It further states that violations constitute unprofessional conduct and require revocation of the provider’s license by the appropriate licensing authority. In addition, the bill creates a private right of action allowing injured individuals to sue healthcare providers, with expanded damages, attorney’s fees, and a long limitations period, while also restricting waivers and confidentiality provisions in settlements.
Impact
HB 1016 would significantly restrict gender-affirming medical care for minors in Missouri by prohibiting certain surgeries and hormone-related treatments for gender transition. It would amend state law governing healthcare provider conduct, professional discipline, and civil liability, while carving out exceptions for treatment of disorders of sex development, treatment of complications from prior procedures, and emergency care for physical illness or injury. The bill would also expose providers to license revocation and civil lawsuits, and it would alter the usual application of chapter 538 in actions brought under the new section.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the measure appears to be framed in strongly restrictive terms and is likely intended to advance a policy position opposed to gender-affirming care for minors. The caption and title language suggest support from sponsors who view the bill as protective of children, while the structure of the bill indicates a highly adversarial approach toward providers offering such care. No formal vote history or hearing record is provided to show broader legislative sentiment.
Contention
The main points of contention are the prohibition on gender transition surgery and hormone or puberty-blocking treatment for minors, the bill’s treatment of such care as unprofessional conduct, and the creation of a private cause of action with enhanced damages and a long filing window. Likely supporters would argue the bill protects minors from irreversible medical interventions, while likely opponents would object that it interferes with medical judgment, targets transgender youth, and imposes severe penalties on healthcare providers. The exceptions for disorders of sex development and emergency treatment may also be debated as narrow carveouts that do not address broader medical concerns.